UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000005839
Receipt No. R000006850
Official scientific title of the study The surveillance study of nausea and vomiting associated with transcatheter arterial chemoembolization for hepatocellular carcinoma
Date of disclosure of the study information 2011/07/01
Last modified on 2017/08/28 (Ver. 6)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study The surveillance study of nausea and vomiting associated with transcatheter arterial chemoembolization for hepatocellular carcinoma
Title of the study (Brief title) The surveillance study of nausea and vomiting associated with transcatheter arterial chemoembolization for hepatocellular carcinoma
Region
Japan

Condition
Condition Hepatocellular carcinoma
Classification by specialty
Hepato-biliary-pancreatic medicine
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 The purpose of this study is to evaluate symptom including nausea and vomiting induced by transacatheter arterial chemoembolization for hepatocellular carcinoma, change of the level of emetic factor including substance P and serotonin, and antiemetic effects of antagonists for NK1 receptor and 5-HT3 receptor.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The primary outcomes of this study is the incidence of nausea and vomiting without antiemetic drugs and the rate of symptom amelioration by antiemetic drugs after transcatheter arterial chemoembolization for hepatocellular carcinoma.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 3
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 control

Interventions/Control_2 NK1 receptor antagonist
Interventions/Control_3 5-HT3 receptor antagonist
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria the patients who are diagnosed as hepatocellular carcinoma and candidates for transcatheter arterial chemoembolization
Key exclusion criteria (1)Child Pugh score C
(2)hepatic encephalopathy II or more
(3)total bilirubin 3.0mg/dL or more
(4)the patients who are treated for neuropsychiatric disorder
(5)the patients who takes anti-anxiety agent
(6)the patients who takes Pimozide
(7)the patients who are judged to be ineligible for entry of this study
Target sample size 300

Research contact person
Name of lead principal investigator Takayuki Yakushijin
Organization Osaka University Graduate School of Medicine
Division name Department of Gastroenterology and Hepatology
Address 2-2 Yamadaoka, Suita, Osaka, Japan
TEL 06-6879-3621
Email yakushijin@gh.med.osaka-u.ac.jp

Public contact
Name of contact person Takayuki Yakushijin
Organization Osaka University Graduate School of Medicine
Division name Department of Gastroenterology and Hepatology
Address 2-2 Yamadaoka, Suita, Osaka, Japan
TEL 06-6879-3621
Homepage URL
Email yakushijin@gh.med.osaka-u.ac.jp

Sponsor
Institute Osaka University Graduate School of Medicine
Institute
Department

Funding Source
Organization Osaka University Graduate School of Medicine
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2011 Year 07 Month 01 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2011 Year 05 Month 12 Day
Anticipated trial start date
2011 Year 07 Month 01 Day
Last follow-up date
2016 Year 03 Month 14 Day
Date of closure to data entry
2016 Year 03 Month 14 Day
Date trial data considered complete
2016 Year 03 Month 14 Day
Date analysis concluded
2016 Year 03 Month 14 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2011 Year 06 Month 23 Day
Last modified on
2017 Year 08 Month 28 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000006850